Mycobacterium tuberculosis Strains from Eastern Siberia Resistant to Bedaquiline and Linezolid: Identification of Novel Mutations
Open Access
- 11 November 2026
- journal article
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 71 (7-8) , 43-49
Abstract
Background . The spread of resistance to bedaquiline and linezolid is a global public health issue across all countries. Investigating the molecular mechanisms underlying this resistance is crucial for curbing the spread of extensively drug-resistant (XDR) tuberculosis. The aim of the study was to identify mutations associated with resistance to bedaquiline and linezolid and to determine the genotypes of 26 Mycobacterium tuberculosis strains circulating in the Irkutsk Region and Yakutia in 2024–2025. Materials and methods . From a collection of 183 strain DNA samples, 26 strains exhibiting phenotypic resistance to bedaquiline and/or linezolid were selected. Sanger sequencing identified mutations listed in the WHO catalog. Additionally, SNP and indel analysis was performed using the previously developed BSATool software. Results. Phenotypically, the isolates were resistant to bedaquiline (16) and linezolid (14); 3 were pre-XDR and 15 were XDR, while the remainder were monoor poly-resistant. Four strains were resistant to both bedaquiline and linezolid. Among the 16 bedaquiline-resistant strains, five had loss-of-function (LoF) mutations, while the other nine carried mutations of uncertain significance. Eleven new mutations were identified, ten of which were conclusively classified as LoF mutations. For two bedaquiline-resistant strains where no SNPs were detected upon amplification of the Rv0678 gene, a significant increase in amplicon size was observed. Further analysis demonstrated that the bedaquiline resistance was caused by the insertion of the IS6110 mobile element at positions 179 and 370 of the Rv0678 gene. The strains belonged to different L2.2 subtypes: B0/W148 and CAO. Conclusion . The widespread use of bedaquiline and linezolid in the treatment of tuberculosis over the past 5 years in the study areas has provided selective advantages for strains implementing various molecular mechanisms of resistance to these drugs. When using molecular tests aimed at determining drug resistance, it is necessary to pay attention to a wide range of changes in the genome of the tuberculosis pathogen, including major genomic rearrangements.Keywords
This publication has 17 references indexed in Scilit:
- Global whole-genome–based genomic insights into Mycobacterium tuberculosis: Clonal dominance, sequence-type structure, and antimicrobial resistance-virulence landscapesInfection, Genetics and Evolution, 2026
- Prevalence of bedaquiline resistance in patients with drug-resistant tuberculosis: a systematic review and meta-analysisBMC Infectious Diseases, 2025
- Online service for interpretation of the resistance prediction results to bedaquiline by the molecular dataActa Biomedica Scientifica, 2024
- Online Service with Automated Interpretation of Sequencing Data and Prediction of Pyrazinamide Resistance in Mycobacterium tuberculosisBulletin of Experimental Biology and Medicine, 2023
- Intragenic Distribution of IS 6110 in Clinical Mycobacterium tuberculosis Strains: Bioinformatic Evidence for Gene Disruption Leading to Underdiagnosed Antibiotic ResistanceMicrobiology Spectrum, 2021
- Molecular epidemiology of multidrug resistant tuberculosis in Mongolia and Eastern Siberia: two independent dissemination processes for dominant strainsRussian Journal of Infection and Immunity, 2020
- Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in ChinaAntimicrobial Agents and Chemotherapy, 2018
- Rapid emergence ofMycobacterium tuberculosisbedaquiline resistance: lessons to avoid repeating past errorsEuropean Respiratory Journal, 2016
- Diversity and Evolution of Mycobacterium tuberculosis: Moving to Whole-Genome-Based ApproachesCold Spring Harbor Perspectives in Medicine, 2014
- First Linezolid-Resistant Clinical Isolates of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007